[Heparin dosage in chronic hemodialysis (author's transl)].
Over a period of 10 months hemodialyses in 20 patients with chronic renal failure were performed with a 40% lower heparin-dose. Blood coagulation was controlled from the activated partial thromboplastin time (APTT). There were no unfavourable side-effects, also the effectivity of the hemodialyses was not changed. However, we measured a significant increase in the hemoglobin-concentration and in the packed cell volume. Bleeding from the punctures was significantly shortened.
D000328:Adult; D000368:Aged; D001780:Blood Coagulation Tests; D005260:Female; D006400:Hematocrit; D006454:Hemoglobins / Q000032:analysis; D006493:Heparin / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D013925:Thromboplastin
D006454:Hemoglobins; D006493:Heparin; D013925:Thromboplastin
Die heparinisierung des chronischen Dialysepatienten.